Insider Sentiment Summary: Drugs

Demo data is delayed six months. Subscribe today and get current information.  Learn More »
Report Time Period: 
Sentiment Summary

Last 4 Weeks

27-Nov-23 - 24-Dec-23
Buy Ratio:57%


# Net Buyers:8
# Net Sellers:6

Previous 4 Weeks

30-Oct-23 - 26-Nov-23
Buy Ratio:44%
# Net Buyers:4
# Net Sellers:5
Buy Ratio History
Number of Companies Filing
Largest Positive Net Change
CompanyNet Buy AmountChange
Neurocrine Biosciences Inc$9.61M$9.61M  
Kalvista Pharmaceuticals, Inc.$6.11M$6.11M  
Vertex Pharmaceuticals Inc / Ma$4.73M$4.73M  
Trevena Inc$679.79K$696.38K  
Sarepta Therapeutics, Inc.--$669.89K  
New Net Buyers
CompanyNet Buy AmountChange
Trevena Inc$679.79K$696.38K  
Largest Negative Net Change
CompanyNet Buy AmountChange
Mannkind Corp($801.93K)($801.93K)  
Zoetis Inc.($682.88K)($682.88K)  
Charles River Laboratories International, Inc.$755.39K($565.16K)  
Harrow, Inc.--($261.56K)  
Vericel Corp($239.49K)($203.13K)  
New Net Sellers
CompanyNet Buy AmountChange
No data found